MS enigma
Next Entries »News from MS market ‘07
Friday, November 16th, 2007The dynamic MS market continues to grow unabated; seven major market revenues increased 14.7% from 2005 to $4.6 billion in 2006. Growth is driven by the highly successful beta-interferon brands, Teva’s Copaxone (glatiramer acetate), and the recent relaunch of Tysabri; the first launch of a new MS treatment for six years [...]
Advantages of MS ! ? !
Tuesday, November 13th, 2007
Inspirational + educational
Multiple Sclerosis, some considerations concerning MS
Here Gerald Hendess from Germany, among others, depicts multiple sclerosis ‘advantages’ of all sorts for different groups.
MS has many advantages in comparison to other diseases
For those patients affected by MS:
The disease is not immediately critical in most cases.
The MS caused disturbances are [...]
MS Treatment Market will Reach $11.9 Billion by 2011
Saturday, November 10th, 2007NewswireToday - Report Buyer, the online destination for business intelligence for major industry sectors, has added a new report showing the growth of MS treatments from $4.4 billion in 2004 to nearly $5.9 billion in 2006
“Multiple Sclerosis: Worldwide Market Outlook to 2011” predicts a growth of $6 million by 2011. The report [...]